亚洲 · 股市与财经 · Pulse (Maeil Business)
Korea’s first homegrown obesity drug wins approval
Hanmi Pharmaceutical’s obesity drug Epe has won regulatory approval and is set to launch by year-end, becoming South Korea’s first domestically developed glucagon-like peptide-1…
在 Pulse (Maeil Business) 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (pulse.mk.co.kr)
